Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, ...

Eli Lilly (NYSE: LLY) doesn’t really need much of an introduction. It has become a household name due to its obesity and ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

GE Aerospace reported Q4 results early Thursday as clear a buy point. Engines, services and defense revenues all climbed.

You can put a lot of time and money into the perfect French dip sandwich, but this recipe ... and smooth before gradually adding the stock, stirring until the stock is incorporated and the gravy ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Co-leading DOGE means Elon Musk is spread increasingly thin. Tesla shareholders told BI that Musk's position could help reduce regulatory red tape for the EV giant. Others said Musk proved his ...

People take pictures on an overpass with a display of stock information in front of buildings in the Lujiazui financial district in Shanghai, China August 6, 2024. REUTERS/Nicoco Chan/File photo ...